Imatinib IP (400mg) Uses, Price, Benefits and More..

IMATIFLOW 400 MG 

Imatinib IP (400mg)

IMATIFLOW 400 MG, containing 400mg of Imatinib IP, is a groundbreaking medication specifically designed for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This targeted therapy marks a significant advancement in oncology, offering patients a highly effective and well-tolerated treatment option.

How IMATIFLOW 400 MG Works

Imatinib IP, the active ingredient in IMATIFLOW 400 MG, is a tyrosine kinase inhibitor that targets and blocks the activity of certain abnormal proteins produced by cancer cells. By inhibiting these proteins, IMATIFLOW 400 MG helps to slow down or stop the growth of cancer cells, leading to improved outcomes for patients with CML and GIST.

Benefits of IMATIFLOW 400 MG

• Targeted Therapy: Acts specifically on cancer cells, minimizing harm to healthy cells and reducing side effects.
• High Efficacy: Demonstrates significant efficacy in controlling CML and GIST, leading to remission and improved quality of life.
• Well-Tolerated: Generally well-tolerated by patients, enhancing treatment adherence and long-term management of the disease.

Why Choose IMATIFLOW 400 MG?

IMATIFLOW 400 MG is a preferred choice for healthcare providers and patients due to its targeted mechanism of action, high efficacy, and favorable safety profile. Its ability to effectively manage CML and GIST with fewer side effects makes it a valuable asset in cancer treatment.

Usage and Dosage

The dosage and administration of IMATIFLOW 400 MG should be determined by an oncologist based on the individual patient's condition, including the type and stage of cancer. It is typically taken orally, with the dose adjusted as needed to achieve optimal therapeutic outcomes.

Safety and Precautions

While IMATIFLOW 400 MG is generally well-tolerated, it can cause side effects such as nausea, fatigue,and fluid retention. Close monitoring by healthcare professionals is important to manage these side effects and ensure the medication's effectiveness.

Conclusion

IMATIFLOW 400 MG represents a significant milestone in cancer treatment, offering targeted and effective therapy for chronic myeloid leukemia and gastrointestinal stromal tumors. With its precision action and favorable safety profile, IMATIFLOW 400 MG provides hope and improved outcomes for patients battling these challenging cancers. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  

For further information:

EMAIL:  info@sterispharma.com  / contact@sterispharma.com

CALL/WHATSAPP:: 7877551268, 7849827488

BUY NOW